About Revonto
Revonto puts time on your side. Revonto is ready to administer in 20 seconds or until the solution is clear.
Revonto offers a significant advancement in patient pharmacotherapy with its improved ease of reconstitution. This feature allows operating room teams to be better equipped to manage an MH crisis. US WorldMeds has introduced Revonto at the same cost-savings as its original generic product.
The use of Revonto in the management of malignant hyperthermia crisis is not a substitute for previously known supportive measures. These measures must be individualized, but it will usually be necessary to discontinue the suspect triggering agents, attend to increased oxygen requirements, manage the metabolic acidosis, institute cooling when necessary, monitor urinary output, and monitor for electrolyte imbalance.
Please see full prescribing information for Revonto.
